ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,964Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 300

$442K Total Retail Price of All Prescriptions

Rank: 51 out of 300

490 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 490 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 9,266 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 684 632 1 2
PRAVASTATIN SODIUM 513 461 2 15
METFORMIN HCL 412 348 3 19
HYDROCHLOROTHIAZIDE 376 322 4 20
HYDROCODONE-ACETAMINOPHEN 371 265 S3 5 1
GLIMEPIRIDE 291 253 6 51
LEVOTHYROXINE SODIUM 282 250 7 9
LISINOPRIL 272 205 8 4
LOSARTAN POTASSIUM 239 220 9 29
FUROSEMIDE 208 181 10 3
LOVASTATIN 200 186 11 68
CARVEDILOL 193 161 12 12
VERAPAMIL ER 183 168 13 113
OMEPRAZOLE 171 128 14 11
POTASSIUM CHLORIDE 162 117 15 22
SIMVASTATIN 150 135 16 5
AMLODIPINE BESYLATE-BENAZEPRIL 139 137 17 52
DOXAZOSIN MESYLATE 136 105 18 90
LOSARTAN-HYDROCHLOROTHIAZIDE 135 125 19 97
TAMSULOSIN HCL 124 108 20 8
GABAPENTIN 120 92 21 7
FLUTICASONE PROPIONATE 115 90 22 34
BENAZEPRIL HCL 107 96 23 73
METOPROLOL TARTRATE 105 97 24 13
WARFARIN SODIUM 96 81 25 10
MELOXICAM 95 87 26 27
ALLOPURINOL 92 83 27 44
PANTOPRAZOLE SODIUM 88 85 28 35
CLONIDINE HCL 87 77 29 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 87 75 29 64
HYDRALAZINE HCL 86 73 31 56
NEXIUM 84 72 32 17
NATEGLINIDE 83 75 33 367
ATENOLOL 82 68 34 31
CRESTOR 78 56 35 26
METOPROLOL SUCCINATE 75 70 36 6
ATORVASTATIN CALCIUM 73 59 37 14
KLOR-CON M20 73 69 37 89
FENOFIBRATE 73 65 37 98
CLOPIDOGREL 72 67 40 18
DONEPEZIL HCL 70 70 41 57
TRAMADOL HCL 67 61 42 23
ALENDRONATE SODIUM 65 59 43 61
ZOLPIDEM TARTRATE 64 63 44 21
TRAZODONE HCL 62 50 45 65
PREDNISONE 60 55 46 33
SYNTHROID 60 57 46 49
ISOSORBIDE MONONITRATE ER 59 50 48 32
BUMETANIDE 58 41 49 126
PLAVIX 57 55 50 24
PEN NEEDLE 56 31 51 194
SERTRALINE HCL 55 31 52 41
ACETAMINOPHEN-CODEINE 55 51 S3 52 232
KLOR-CON M10 51 41 54 311
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.